A Safety and Effectiveness Study of JNJ-31001074 in Adults With Attention-Deficit/Hyperactivity Disorder.

Completed · Phase 2 · Has a placebo group

Conditions studied: Attention Deficit Hyperactivity Disorder

In brief

The purpose of this study is to evaluate the safety and effectiveness of JNJ-31001074 compared to placebo in adults with Attention Deficit Hyperactivity Disorder (ADHD).

Key facts

Study ID

NCT00566449

Run by

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

People needed

32

Starts

2007-12-01

Expected to finish

2008-07-01

Last updated by the study team

2014-05-13

Who can join

Age: 18 and older, up to 64. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of attention deficit hyperactivity disorder with symptoms from age 7
• In good general health
• Willing to not take any other ADHD medication or start any behaviorial modification programs during the study
• Willing to use approved birth control throughout the study and for 3 months afterwards

You may not qualify if…

• Any psychiatric condition including acute mood disorder, bipolar disorder, acute obsessive-compulsive disorder (OCD), anti-social personality disorder or borderline personality disorder
• Autism, asperger's syndrome, mental retardation
• Presence of motor tics, history of Tourette's syndrome or family history of Tourette's syndrome
• History of substance use/abuse disorder or eating disorder
• History of myocardial infarction, stroke, glaucoma, seizures, hypertension, heart rhythm abnormalities or color blindness
• Use of prescription medication or herbal supplements

Where it is running

• Study site — Irvine, California, United States
• Study site — Lafayette, California, United States
• Study site — San Francisco, California, United States
• Study site — Bradenton, Florida, United States
• Study site — Fort Myers, Florida, United States
• Study site — Orlando, Florida, United States
• Study site — South Miami, Florida, United States
• Study site — Eagle, Idaho, United States
• Study site — Libertyville, Illinois, United States
• Study site — Overland Park, Kansas, United States
• Study site — Boston, Massachusetts, United States
• Study site — Farmington, Michigan, United States
• Study site — Chapel Hll, North Carolina, United States
• Study site — Raleigh, North Carolina, United States
• Study site — Dayton, Ohio, United States
• Study site — Portland, Oregon, United States
• Study site — Media, Pennsylvania, United States
• Study site — Austin, Texas, United States
• Study site — Houston, Texas, United States
• Study site — Herndon, Virginia, United States
• Study site — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.